Viewing Study NCT00483834


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-31 @ 10:41 PM
Study NCT ID: NCT00483834
Status: COMPLETED
Last Update Posted: 2019-02-15
First Post: 2007-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module